The incidence of post‐transplant malignancies in kidney transplant recipients treated with Rituximab-Reference-Cited by-同舟云学术

The incidence of post‐transplant malignancies in kidney transplant recipients treated with Rituximab

Published:2020-12-12 Issue:2 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Bachelet Thomas¹²^ORCID,Visentin Jonathan³⁴,Davis Philippine²,Taton Benjamin²,Guidicelli Gwendaline³,Kaminski Hannah²⁴,Merville Pierre²⁴,Couzi Lionel²⁴

Affiliation:

1. Clinique Saint‐Augustin‐CTMR Bordeaux ELSAN France

2. Department of Nephrology, Transplantation, Dialysis and Apheresis Bordeaux University Hospital Bordeaux France

3. Immunology and Immunogenetics Laboratory Bordeaux University Hospital Bordeaux France

4. ImmunoConcEpT UMR 5164 Bordeaux University CNRS Bordeaux France

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14171

Reference52 articles.

1. Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes

2. Desensitization in HLA-Incompatible Kidney Recipients and Survival

3. Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis

4. Value of Donor–Specific Anti–HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss

5. A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma and cancer-related mortality after kidney transplantation with rituximab treatment;Annals of Surgical Treatment and Research;2022

2. Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis;Cancer Cell International;2021-11-22

3. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs;Immunopharmacology and Immunotoxicology;2021-08-20